SUNESIS PHARMACEUTICALS INC (34) | Human Resources (12)

Browse by Subcategory

Recent Contracts

Executive Incentive Compensation Plan (Filed With SEC on March 17, 2022)
Amendment to Employment Agreement between Viracta Therapeutics, Inc. and Ivor Royston, M.D., dated August 12, 2021 (Filed With SEC on August 12, 2021)
Amended and Restated Outside Director Compensation Plan (Filed With SEC on May 13, 2021)
Form of Executive Severance Benefits Agreement between Sunesis Pharmaceuticals, Inc. and certain officers (Filed With SEC on December 22, 2020)
Form of Retention Benefits Letter between Sunesis Pharmaceuticals, Inc. and certain officers (Filed With SEC on November 30, 2020)
Consulting Agreement, dated May 2, 2020, by and between the Registrant and William P. Quinn (Filed With SEC on August 11, 2020)
2021 Inducement Equity Incentive Plan and form of agreement thereunder (Filed With SEC on August 12, 2021)
Amendment to Employment Agreement between Viracta Therapeutics, Inc. and Daniel Chevallard, dated August 12, 2021 (Filed With SEC on August 12, 2021)
Amendment to Employment Agreement between Viracta Therapeutics, Inc. and Lisa Rojkjaer, M.D., dated August 12, 2021 (Filed With SEC on August 12, 2021)
Executive Severance Benefits Agreement, dated May 4, 2020, by and between the Registrant and Tina Gullotta (Filed With SEC on August 11, 2020)
Sunesis Pharmaceuticals, Inc. 2020 Bonus Program (Filed With SEC on February 14, 2020)
Sunesis Pharmaceuticals, Inc. 2019 Bonus Program (Filed With SEC on February 4, 2019)